{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:02:25Z","timestamp":1762459345133},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/cgt.2015.43","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T10:26:10Z","timestamp":1442571970000},"page":"506-508","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["HSV-1 as a novel therapy for breast cancer meningeal metastases"],"prefix":"10.1038","volume":"22","author":[{"given":"D","family":"Kuruppu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K K","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"BFcgt201543_CR1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/CCO.0b013e32833de986","volume":"22","author":"MC Chamberlain","year":"2010","unstructured":"Chamberlain MC . Leptomeningeal metastasis. Curr Opin Oncol 2010; 22: 627\u2013635.","journal-title":"Curr Opin Oncol"},{"key":"BFcgt201543_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s12032-012-0408-4","volume":"30","author":"A Niwi\u0144ska","year":"2013","unstructured":"Niwi\u0144ska A, Rudnicka H, Murawska M . Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival. Med Oncol 2013; 30: 408.","journal-title":"Med Oncol"},{"key":"BFcgt201543_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-008-9758-3","volume":"93","author":"F Waki","year":"2009","unstructured":"Waki F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M et al. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 2009; 93: 205\u2013212.","journal-title":"J Neurooncol"},{"key":"BFcgt201543_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10549-011-1417-2","volume":"127","author":"M Oliveira","year":"2011","unstructured":"Oliveira M, Braga S, Passos-Coelho JL, Fonseca R, Oliveira J . Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab. Breast Cancer Res Treat 2011; 127: 841\u2013844.","journal-title":"Breast Cancer Res Treat"},{"key":"BFcgt201543_CR5","first-page":"1010","volume":"10","author":"L Harstad","year":"2008","unstructured":"Harstad L, Hess KR, Groves MD . Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. J Neurooncol 2008; 10: 1010\u20131018.","journal-title":"J Neurooncol"},{"key":"BFcgt201543_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/156800907780058871","volume":"7","author":"D Kuruppu","year":"2007","unstructured":"Kuruppu D, Dorfman JD, Tanabe KK . HSV-1 viral oncolysis and molecular imaging with PET. Curr Cancer Drug Targets 2007; 7: 175\u2013180.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFcgt201543_CR7","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1158\/0008-5472.CAN-13-3472","volume":"74","author":"D Kuruppu","year":"2014","unstructured":"Kuruppu D, Brownell AL, Shah K, Mahmood U, Tanabe KK . Molecular imaging with bioluminescence and PET reveals viral oncolysis kinetics and tumor viability. Cancer Res 2014; 74: 4111\u20134121.","journal-title":"Cancer Res"},{"key":"BFcgt201543_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4161\/cbt.4.5.1820","volume":"4","author":"D Kuruppu","year":"2005","unstructured":"Kuruppu D, Tanabe KK . Viral oncolysis by herpes simplex virus and other viruses. Cancer Biol Ther 2005; 4: 524\u2013531.","journal-title":"Cancer Biol Ther"},{"key":"BFcgt201543_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/cgt.2011.80","volume":"19","author":"TT Sahin","year":"2012","unstructured":"Sahin TT, Kasuya H, Nomura N, Shikano T, Yamamura K, Gewen T et al. Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer. Cancer Gene Ther 2012; 19: 229\u2013237.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201543_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/cgt.2014.28","volume":"21","author":"S Gholami","year":"2014","unstructured":"Gholami S, Chen CH, Gao S, Lou E, Fujisawa S, Carson J et al. Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer. Cancer Gene Ther 2014; 21: 283\u2013289.","journal-title":"Cancer Gene Ther"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201543","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:32:08Z","timestamp":1647952328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFcgt201543"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2015.43","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,18]]},"assertion":[{"value":"26 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}